XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic and diluted earnings (loss) per share is calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings (loss) per share. A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share follows (dollars in millions, except per share amounts; shares in thousands):
|  | Three Months Ended September 30, |  |  |  | Nine Months Ended September 30,
|  | 2024 |  | 2023 |  |  |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |  |  |  |
Net loss attributable to Surgery Partners, Inc. |  | $ | (31.7) |  |  | $ | (4.9) |  |  |  |  | $ | (59.6) |  |  | $ | (10.9) |
Denominator: |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding: |  |  |  |  |  |  |  |  |  |
Basic |  | 126,172 |  |  | 125,747 |  |  |  |  | 126,093 |  |  | 125,559 |
Diluted (1) |  | 126,172 |  |  | 125,747 |  |  |  |  | 126,093 |  |  | 125,559 |
Net loss per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.25) |  |  | $ | (0.04) |  |  |  |  | $ | (0.47) |  |  | $ | (0.09) |
Diluted (1) |  | $ | (0.25) |  |  | $ | (0.04) |  |  |  |  | $ | (0.47) |  |  | $ | (0.09) |
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive: |  |  |  |  |  |  |  |  |  |
Stock options |  | 1,187 |  |  | 1,421 |  |  |  |  | 1,164 |  |  | 1,412 |
Restricted shares |  | 281 |  |  | 208 |  |  |  |  | 264 |  |  | 202 |
(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration